スポンサーリンク
Tokyo Research Laboratories, Kowa Co., Ltd. | 論文
- Localization of Tissue Plasminogen Activator on Experimental Thrombi in Rats
- PHARMACOKINETICS OF NIPRADILOL (K-351), A NEW ANTIHYPERTENSIVE AGENT. I. STUDIES ON INTERSPECIES VARIATION IN LABORATORY ANIMALS
- PHARMACOKINETICS OF NIPRADILOL (K-351), A NEW ANTIHYPERTENSIVE AGENT. II. INFLUENCE OF THE ROUTE OF ADMINISTRATION ON BIOAVAILABILITY IN DOGS
- Stimulation of PGI_2 Production by Uric Acid or Tyramine in Rat Aorta Preparations(Biological Chemistry)
- Potentiating Factors of PGI_2 Production of Rat Aortic Ring Preparations(Biological Chemistry)
- Purification and Identification of a Stimulator of PGI_2 Production from Human Placenta(Biological Chemistry)
- Isolation and Identification of Two Stimulators of PGI_2 Production from Fetal Calf Serum(Biological Chemistry)
- EFFECT OF VEHICLE COMPOSITION ON THE PERCUTANEOUS ABSORPTION OF INDOMETHACIN
- AN ANALYSIS OF 5-HT HYPERPOLARIZATION OF SYMPATHETIC GANGLION CELLS
- EFFECTS OF DILAZEP ON FIBRINOLYTIC SYSTEM IN ANIMALS. I. ENHANCEMENT OF FIBRINOLYTIC ACTIVITY BY ADMINISTERED DILAZEP IN EX VIVO EXPERIMENT
- Venodilating action of nipradilol (K-351) in the pithed rat pretreated with dihydroergotamine.
- Pharmacokinetics of nipradilol (K-351), a new antihypertensive agent, in human.
- Venous Distensibility in Stroke-Prone SHR at 6 and 15 Weeks of Age---Comparison with Age-Matched WKY---
- Potential effectiveness of minidose aspirin combined with dilazep in anti-platelet therapy.
- Anaerobic Coryneforms Isolated from Human Bone Marrow and Skin:Chemical, Biochemical and Serological Studies and Some of Their Biological Activities